It's Not Moderation. It's Medication.

About 1 in 8 American adults has now taken a GLP-1. Morgan Stanley says 62% of them cut back on alcohol and a quarter stopped drinking entirely. That is not a wellness trend you ride out. That is a prescription quietly redrawing the demand curve under your category.

For two years the official explanation for soft volume has been Gen Z and "the moderation movement." It is a comfortable story. Young people are drinking less, everyone is being healthier, this too shall pass. The problem is that even the people selling the most spirits do not believe it. Diageo's own CEO called the Gen-Z-is-health-conscious narrative "bullshit." Rabobank put it more politely: Gen Z is drinking less mostly because they have less money and a third of them are underage. The moderation story is a blanket thrown over a structural change nobody wants to name out loud.

What is actually happening

GLP-1s blunt the brain's reward response, and alcohol is one of the first things to go. EY found 44% of users drink less after starting. The number that should keep you up at night is the next one: 82% of them hold those new habits even after they stop taking the drug. This is not Dry January. It is a behavior reset, and it is happening in the households that buy the most.

It is also hitting where it hurts most. Roughly a third of heavy drinkers on GLP-1s report cutting back. Heavy drinkers are not the edge of your volume. They are the center of it. Lose a slice of them and you do not lose a slice of your sales, you lose the load-bearing wall.

For brand operators, this rewrites the math on every distributor conversation. If your pitch still assumes a stable base of regular buyers trading up, you are selling into a market shrinking from the inside. Spirits actually held up better per drinker than wine, 40% cutting back versus 52%. Small comfort. The pool itself is contracting, and Morgan Stanley projects 31.5 million users by 2035. You cannot grow share fast enough to outrun a base that is quietly opting out.

So here is the uncomfortable question. If your category's softness is structural and not cyclical, what exactly are you waiting to bounce back?

What to do about it

1. Kill the "return to normal" forecast and plan for a permanently smaller heavy-user base.
2. Sell occasions, not volume. The drinkers who stay want fewer and better, so fight for premium placement and trial over case stacks.
3. Pressure-test your portfolio for who is actually still buying, then aim your distributor programming at those accounts instead of the whole map.